Enanta Pharmaceuticals (ENTA)
(Delayed Data from NSDQ)
$12.58 USD
-0.91 (-6.75%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $12.55 -0.03 (-0.24%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Earnings News For ENTA
-
Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates
-
Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter
-
Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot
-
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
-
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
-
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates
-
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
-
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
-
Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET
-
Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for
-
Enanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Full Year Ended September 30, 2023
-
Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates
-
Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter with Conference Call and Webcast Today at 4:30 p.m. ET
-
Enanta Pharmaceuticals to Host Conference Call on August 7 at 4:30 p.m. ET to Discuss its Financial Results for Its Fiscal Third Quarter Ended June 30, 2023
-
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Misses Revenue Estimates
-
Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Conference Call and Webcast Today at 4:30 p.m. ET
-
Enanta Pharmaceuticals to Host Conference Call on May 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2023
-
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates
-
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot